Eton Pharmaceuticals (ETON) Total Liabilities (2017 - 2025)

Eton Pharmaceuticals has disclosed Total Liabilities across 9 years of filings, most recently posting $66.0 million for Q4 2025.

• Total Liabilities for Q4 2025 came in at $66.0 million, up 27.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $66.0 million (up 27.59% YoY), and the FY2025 annual result was $66.0 million, up 27.59% from the prior year.
• Total Liabilities came in at $66.0 million for Q4 2025 at Eton Pharmaceuticals, down from $81.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $81.4 million in Q3 2025 to a low of $9.2 million in Q2 2021.
• The 5-year median for Total Liabilities is $14.4 million (2023), against an average of $26.5 million.
• Across the five-year window, Total Liabilities retreated 7.7% in 2021 and soared 323.26% in 2025, its largest moves.
• Eton Pharmaceuticals' Total Liabilities stood at $9.8 million in 2021, then advanced by 21.53% to $12.0 million in 2022, then surged by 36.07% to $16.3 million in 2023, then surged by 217.87% to $51.7 million in 2024, then increased by 27.59% to $66.0 million in 2025.
• The last three Total Liabilities figures came in at $66.0 million (Q4 2025), $81.4 million (Q3 2025), and $77.7 million (Q2 2025), per Business Quant data.